# US 2014/0207251 A1 · Bio-selective surface textures

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2014/0207251 A1
- Document ID: US20140207251A1
- Status: Published application
- Kind: A1
- Application number: 13/745,406
- Filed: 2013-01-18
- Published: 2014-07-24
- Earliest claimed: 2013-01-11
- Assignees: BVW Holding AG
- Applicants: Bvw Holding AG
- Inventors: Lukas Bluecher; Michael Milbocker
- Web page: https://patentgrep.com/patent/US20140207251A1

## CPC

- A61F 2/02: Prostheses implantable into the body
- A61F 2/0063: {Implantable repair or support meshes, e.g. hernia meshes}
- A61F 2/0077: {Special surfaces of prostheses, e.g. for improving ingrowth (A61F2/30767 takes precedence)}
- A61L 27/34: Macromolecular materials
- A61L 27/50: Materials characterised by their function or physical properties {, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials}
- A61L 27/54: Biologically active materials, e.g. therapeutic substances {(A61L27/227 takes precedence)}
- A61L 27/56: Porous materials, {e.g. foams or sponges}
- A61L 31/10: Macromolecular materials
- A61L 31/14: Materials characterised by their function or physical properties {, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials}
- A61L 31/146: {Porous materials, e.g. foams or sponges}
- B29C 33/3842: {Manufacturing moulds, e.g. shaping the mould surface by machining}
- A61F 2002/0086: {for preferentially controlling or promoting the growth of specific types of cells or tissues}
- A61F 2002/009: {for hindering or preventing attachment of biological tissue}
- A61F 2210/0004: bioabsorbable
- A61L 2400/18: Modification of implant surfaces in order to improve biocompatibility, cell growth, fixation of biomolecules, e.g. plasma treatment
- A61F: FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS (dental prosthetics A61C)
- A61L: METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES (preservation of bodies or disinfecting characterised by the agents employed A01N; preserving, e.g. sterilising, food or foodstuffs A23; preparations for medical, dental or toiletry purposes A61K)
- B29C: SHAPING OR JOINING OF PLASTICS; SHAPING OF MATERIAL IN A PLASTIC STATE, NOT OTHERWISE PROVIDED FOR; AFTER-TREATMENT OF THE SHAPED PRODUCTS, e.g. REPAIRING (making preforms B29B11/00; making laminated products by combining previously unconnected layers which become one product whose layers will remain together B32B37/00 - B32B41/00)

## Abstract

Bio-selective textured surfaces are described which mediate foreign body response, bacterial adhesion, and tissue adhesion on devices implanted in a mammalian body. Hierarchical levels of texture, some capable of establishing a Wenzel state others a Cassie state, are employed to interface with living structures, either to promote or discourage a particular biological response/interaction. Since a gaseous state is traditionally required to establish a Cassie or Wenzel state, and gases do not remain long in living tissue, described are tissue/device interactions analogous to the above states with the component normally represented by a gas replaced by a bodily constituent, wherein separation of tissue constituents develops and a desired interaction state evolves.

## Claims

### Claim 1

An implantable medical device comprising at least two surface textures on a substrate, wherein upon implantation in a host tissue the surface textures form interfaces with liquids present in the host tissue, wherein
a first surface texture traps air between the device and the tissue to form a first interface; and
a second surface texture does not trap air between the device and the host tissue to form a second interface;
wherein the interfaces have a contact hysteresis angle of at least 5 degrees.

### Claim 2 (depends on 1)

The implantable medical device of claim 1, wherein after a period of time, the interfaces comprise: a) a solid hydrophilic phase, b) a liquid hydrophobic phase, and c) a liquid hydrophilic phase.

### Claim 3 (depends on 1)

The implantable medical device of claim 1, wherein the trapped air is replaced by a liquid hydrophobic phase after a period of time.

### Claim 4 (depends on 1)

The implantable medical device of claim 1, wherein the surface textures comprise hydrophilic absorbable materials, wherein the hydrophilic absorbable materials are made less hydrophilic by the surface textures, and the surface textures reduce a rate of absorption or conformal change of the medical device in the host tissue.

### Claim 5 (depends on 1)

The implantable medical device of claim 1, wherein the surface textures comprise hydrophobic absorbable materials, wherein the hydrophobic absorbable materials are made less hydrophobic by the surface textures, and the surface textures increase a rate of absorption or conformal change of the medical device in the host tissue.

### Claim 6 (depends on 1)

The implantable medical device of claim 1, wherein at least one surface texture comprises absorbable materials, wherein the at least one surface texture is modified by absorption, such that the at least one surface texture becomes more wetting or less wetting as the medical device is absorbed.

### Claim 7 (depends on 1)

The implantable medical device of claim 1, wherein the surface textures have a rate of absorbance in the host tissue that mitigates tissue adhesion, bacterial colonization, and/or biofilm formation during a first time interval, and wherein the surface textures become a smooth, hydrophilic, rapidly absorbing and non-fibrogenic material during a second time interval.

### Claim 8 (depends on 1)

The implantable medical device of claim 1, wherein at least one surface texture comprises a smaller pitch of 10 nanometers to 1 micron, and at least one surface texture comprises a larger pitch of 2 microns to 100 microns, wherein the smaller pitch surface texture is disposed on the larger pitch surface texture, wherein at least one interface excludes attachment of a first tissue species and another interface promotes attachment of a second tissue species.

### Claim 9 (depends on 8)

The implantable medical device of claim 8, wherein the first tissue species is a microbe and the second tissue species is host cells.

### Claim 10 (depends on 8)

The implantable medical device of claim 8, wherein the first tissue species is a protein and the second tissue species is host tissue.

### Claim 11 (depends on 8)

The implantable medical device of claim 8 wherein the first tissue species is host tissue and the second tissue species is endothelial cells.

### Claim 12 (depends on 1)

The implantable medical device of claim 1, wherein upon implantation in the host tissue, a surface charge of at least one surface texture increases such that water is more strongly bonded to the substrate surface, but not so strongly bonded so as to preclude exchange of water molecules bonded to said substrate surface with surrounding water in the host tissue.

### Claim 13 (depends on 12)

The implantable medical device of claim 12, wherein a layer of water adheres to the surface textures of the device, and the water layer reduces a rate of protein molecule adsorption to the textured surface, relative to a device without the surface textures.

### Claim 14 (depends on 1)

The implantable medical device of claim 1, wherein the substrate is porous.

### Claim 15 (depends on 1)

The implantable medical device of claim 1, wherein the first surface texture forms a Cassie state when implanted in host tissue and the second surface texture forms a Wenzel state when implanted in host tissue.

### Claim 16 (depends on 1)

The implantable medical device of claim 1, wherein at least one of the surface textures comprises fibers embedded in and protruding from the substrate, and the fibers are bifurcated at least once on at least one spatial scale different from a pitch of other surface textures of the device.

### Claim 17 (depends on 1)

The implantable medical device of claim 1 wherein at least one of the surface textures comprises fibers embedded at both ends in the substrate, such that the fibers form loops protruding from the substrate, wherein the fibers have at least one diameter different from a pitch of the other surface textures of the medical device.

### Claim 18 (depends on 1)

The implantable medical device of claim 1, wherein at least one surface texture comprises a Koch snowflake pattern.

### Claim 19 (depends on 1)

The implantable medical device of claim 1, wherein at least one surface texture comprises a Sierpinski gasket pattern.

### Claim 20 (depends on 1)

The implantable medical device of claim 1 wherein at least one surface texture comprises an Apollonian gasket pattern.

### Claim 21 (depends on 1)

The implantable medical device of claim 1, wherein at least one surface texture comprises a diffusion limited aggregation pattern.

### Claim 22

An implantable medical device comprising two sides, each side comprising surface textures on a substrate, wherein upon implantation in a host tissue the surface textures form interfaces with liquids present in host tissue, wherein at least one surface texture traps air between the device and tissue and at least one other surface texture does not trap air between the device and tissue, and wherein the resulting interfaces generate a contact hysteresis angle of at least 5 degrees on one side of the device and less than 5 degrees on the other side of the device.

### Claim 23 (depends on 22)

The implantable medical device of claim 22, wherein after a period of time, the interfaces comprise: a) a solid hydrophilic phase, b) a liquid hydrophobic phase, and c) a liquid hydrophilic phase.

### Claim 24 (depends on 22)

The implantable medical device of claim 22 wherein the trapped air is replaced by a liquid hydrophobic phase after a period of time.

### Claim 25 (depends on 22)

The implantable medical device of claim 22, wherein at least one side comprises hydrophilic absorbable materials, wherein the hydrophilic absorbable materials are made less hydrophilic by the addition of the surface textures, and the surface textures reduce a rate of absorption or conformal change of the medical device in the host tissue.

### Claim 26 (depends on 22)

The implantable medical device of claim 22, wherein at least one side comprises hydrophobic absorbable materials, wherein the hydrophobic absorbable materials are made less hydrophobic by the surface textures, and the surface textures increase a rate of absorption or conformal change of the medical device in situ.

### Claim 27 (depends on 22)

The implantable medical device of claim 22, wherein at least one surface texture on at least one side comprises absorbable materials, wherein the at least one surface texture is modified by absorption, such that the at least one surface texture becomes more wetting or less wetting as the medical device is absorbed.

### Claim 28 (depends on 22)

The implantable medical device of claim 22, wherein the surface textures have a rate of absorbance in the host tissue that mitigates tissue adhesion, bacterial colonization, and or biofilm formation during a first time period, and wherein the surface textures become a smooth, hydrophilic, rapidly absorbing and non-fibrogenic material during a second time interval.

### Claim 29 (depends on 22)

The implantable medical device of claim 22, wherein at least one side comprises at least two surface textures, wherein at least one surface texture comprises a smaller pitch of 10 nanometers to 1 micron, and a second surface texture comprises a larger pitch of 2 microns to 100 microns, wherein the smaller pitch surface texture is disposed on the larger pitch surface texture, wherein when said medical device is implanted at least two interfaces with living tissue are formed, wherein at least one interface excludes attachment of a first tissue species and at least one other interface promotes attachment of a second tissue species.

### Claim 30 (depends on 29)

The implantable medical device of claim 29 wherein the first tissue species is a microbe and the second tissue species is host cells.

### Claim 31 (depends on 29)

The implantable medical device of claim 29 wherein the first tissue species is a protein and the second tissue species is host tissue.

### Claim 32 (depends on 29)

The implantable medical device of claim 29 wherein the first tissue species is host tissue and the second tissue species is endothelial cells.

### Claim 33 (depends on 22)

The implantable medical device of claim 22, wherein upon implantation in the host tissue, a surface charge of at least one surface texture increases such that water is more strongly bonded to the substrate surface, but not so strongly bonded so as to preclude exchange of water molecules bonded to the surface texture with surrounding water in said host tissue.

### Claim 34 (depends on 33)

The implantable medical device of claim 33, wherein a layer of water adheres to the surface textures of the device, and the water layer reduces a rate of protein molecule adsorption to the textured surface, relative to a device without the surface textures.

### Claim 35 (depends on 22)

The implantable medical device of claim 22, wherein the substrate is porous.

### Claim 36 (depends on 22)

The implantable medical device of claim 22, wherein at least one of surface texture forms a Cassie state when implanted in the host tissue and at least one other surface texture forms a Wenzel state when implanted in host tissue.

### Claim 37 (depends on 22)

The implantable medical device of claim 22, wherein at least one of said surface textures is comprises fibers embedded in and protruding from the substrate, and the fibers are bifurcated at least once on at least one spatial scale different from a pitch of other surface textures on the medical device.

### Claim 38 (depends on 22)

The implantable medical device of claim 22, wherein at least one of the surface textures comprises fibers embedded at both ends in the substrate, such that the fibers form loops protruding from the substrate, wherein the fibers have at least one diameter different from a pitch of the other surface textures of medical device.

### Claim 39 (depends on 22)

The implantable medical device of claim 22, wherein at least one surface texture comprise a Koch snowflake pattern.

### Claim 40 (depends on 22)

The implantable medical device of claim 22, wherein at least one surface texture comprises a Sierpinski gasket pattern.

### Claim 41 (depends on 22)

The implantable medical device of claim 22, wherein at least one surface texture comprises an Apollonian gasket pattern.

### Claim 42 (depends on 22)

The implantable medical device of claim 22, wherein at least one surface texture comprises a diffusion limited aggregation pattern.
